Welcome Guest to Happi

Subscribe Free: Magazine | eNewsletter

current issue October 2014
 •  L'OrĂ©al USA To Buy Carol's Daughter  •  Industry Remembers Oscar de la Renta  •  Dr. Bronner's Major Ad Buy  •  Brilliant Group Opens California Facility  •  Satisfaction with Household Products Drops in Annual Survey
Print

Syn-tacks from Pentapharm



Published May 2, 2007
Related Searches: active design aging cosmetics
Post a comment
Pentapharm’s new peptide complex Syn-Tacks was unveiled at In-Cosmetics 2007 Paris. The new active ingredient is a highly effective peptide complex for anti-aging treatments to preserve and redesign the Dermal Epidermal Junction (DEJ). Syn-Tacks combines two different peptides and stimulates Laminin V, collagen types IV, VII and XVII and Integrin all at once. This activity achieves the utmost anti-aging benefit for the skin, according to the company. In vivo data show in different studies a significant effect on cellular cohesion and skin tone and elasticity. The product was also very well received and rated by means of an evaluation questionnaire.

More info: www.pentapharm.com


blog comments powered by Disqus